Baihua Pharmaceutical (600721.SH) released its performance for the first half of the year, with a net profit attributable to shareholders of 25.48 million yuan, an increase of 12.45% year-on-year.

The Zhitong Financial APP reported that Baihua Pharmaceuticals (600721.SH) released its semi-annual report for 2025. During the reporting period, the company achieved operating income of 202 million yuan, a year-on-year increase of 2.95%. The net profit attributable to the shareholders of the listed company was 25.4834 million yuan, a year-on-year increase of 12.45%. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 24.0587 million yuan, a year-on-year increase of 13.82%. The basic earnings per share were 0.0663 yuan.